Titan Medical and Mimic Technologies Announce Successful Completion of Core Surgical Skills Simulation Modules
September 18 2018 - 09:15AM
Titan Medical Inc. (“Titan” or the “Company”)
(TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the
design, development and commercialization of a robotic surgical
system for application in single-port minimally invasive surgery
(“MIS”) and
Mimic Technologies Inc. (“Mimic”), a
market leader in robotic simulation, announce the successful
completion of the core surgical skills simulation modules for use
with Titan’s SPORT Surgical System surgeon workstation.
The successful demonstration and delivery of 14
core skills simulation modules is an important milestone in the
completion of the first phase of a comprehensive surgeon training
curriculum Titan is planning for its SPORT Surgical System. A brief
video of the demonstration of a subset of the simulation modules is
available here.
David McNally, President and CEO of Titan
Medical, said, “Since announcing initiation of this program in
March, the Titan and Mimic teams, with years of robotic expertise
coupled with hands-on surgeon feedback acquired during early
feasibility studies, carefully crafted the foundational curriculum
to facilitate the acquisition of core surgical skills when using
the SPORT system. Simulation-based training and skills acquisition
are vital for surgeon and OR staff robotic training. These
skills are intended to accelerate clinical adoption of the SPORT
system following commercialization. We are thrilled to announce the
completion of this important milestone ahead of schedule. Our
collaboration with Mimic has been exceptionally productive and we
look forward to working with them to evolve our advanced surgical
skills curriculum in the future.”
Jeff Berkley, CEO and Founder of Mimic
Technologies, said, “Mimic is pleased to deliver a comprehensive
set of core surgical skills simulation modules for the SPORT
system. We have enjoyed a fruitful collaboration with Titan and its
surgeon advisors, which has resulted in a custom curriculum that
specifically targets key learning objectives for single-port
robotic surgery. There is strong clinical evidence that suggests
substantial simulation training can rapidly accelerate surgeon
learning while significantly improving patient outcomes. We are
excited about what the future holds for single-port robotic surgery
and the important role simulation will play in potentially making
it the new standard of care.”
About MimicSince 2002, Mimic
has been developing simulation technologies that answer the needs
of a changing robotic surgical marketplace. Mimic provides
simulation solutions that help medical device companies build
better robots and training simulators for surgeons. Mimic also
provides strategic solutions for hospitals that maximize surgical
quality, efficiency and safety, while reducing risk and costs.
Mimic’s programmatic approach unifies training and testing across a
hospital system to ensure hospital stakeholders can make objective
decisions on who is safe to enter the OR.
For more information, please visit the Company’s
website at www.mimicsimulation.com.
About TitanTitan Medical Inc.
is focused on research and development through to the planned
commercialization of computer-assisted robotic surgical
technologies for application in minimally invasive surgery. The
Company is developing the SPORT Surgical System, a single-port
robotic surgical system. The SPORT Surgical System is comprised of
a surgeon-controlled patient cart that includes a 3D
high-definition vision system and multi-articulating instruments
for performing MIS procedures, and a surgeon workstation that
provides an advanced ergonomic interface to the patient cart and a
3D endoscopic view inside the patient’s body. Titan intends to
initially pursue focused surgical indications for the SPORT
Surgical System, which may include one or more of gynecologic,
urologic, colorectal or general abdominal procedures.
For more information, please visit the Company’s
website at www.titanmedicalinc.com.
Forward-Looking StatementsThis
news release contains “forward-looking statements” within the
meaning of applicable Canadian and U.S. securities laws. Such
statements reflect the current expectations of management of the
Company’s future growth, results of operations, performance and
business prospects and opportunities. Wherever possible, words such
as “may”, “would”, “could”, “will”, “anticipate”, “believe”,
“plan”, “expect”, “intend”, “estimate”, “potential for” and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management’s current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the “Risk Factors” section of the Company’s Annual
Information Form dated March 31, 2018 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results, performance, or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully, and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements. Except as
required by law, the Company expressly disclaims any intention or
obligation to update or revise any forward-looking statements
whether as a result of new information, future events or
otherwise.
Contacts:
LHA Investor Relations Kim Sutton Golodetz(212)
838-3777kgolodetz@lhai.com orBruce Voss(310) 691-7100
bvoss@lhai.com
Titan Medical (TSX:TMD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Titan Medical (TSX:TMD)
Historical Stock Chart
From Mar 2023 to Mar 2024